6VO1 image
Deposition Date 2020-01-29
Release Date 2020-07-01
Last Version Date 2024-10-30
Entry Detail
PDB ID:
6VO1
Keywords:
Title:
BG505 SOSIP.v5.2 in complex with rhesus macaque Fab RM20J
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.88 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp120
Gene (Uniprot):env
Chain IDs:A, E (auth: C), I (auth: D)
Chain Length:475
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:Envelope glycoprotein gp41
Gene (Uniprot):env
Chain IDs:B, F (auth: E), J (auth: F)
Chain Length:153
Number of Molecules:3
Biological Source:Human immunodeficiency virus 1
Polymer Type:polypeptide(L)
Molecule:RM20J Heavy chain Fab
Chain IDs:C (auth: H), G, K (auth: I)
Chain Length:118
Number of Molecules:3
Biological Source:Macaca mulatta
Polymer Type:polypeptide(L)
Molecule:RM20J Kappa light chain
Chain IDs:D (auth: L), H (auth: J), L (auth: K)
Chain Length:107
Number of Molecules:3
Biological Source:Macaca mulatta
Ligand Molecules
Primary Citation

Abstact

The induction of broad and potent immunity by vaccines is the key focus of research efforts aimed at protecting against HIV-1 infection. Soluble native-like HIV-1 envelope glycoproteins have shown promise as vaccine candidates as they can induce potent autologous neutralizing responses in rabbits and non-human primates. In this study, monoclonal antibodies were isolated and characterized from rhesus macaques immunized with the BG505 SOSIP.664 trimer to better understand vaccine-induced antibody responses. Our studies reveal a diverse landscape of antibodies recognizing immunodominant strain-specific epitopes and non-neutralizing neo-epitopes. Additionally, we isolated a subset of mAbs against an epitope cluster at the gp120-gp41 interface that recognize the highly conserved fusion peptide and the glycan at position 88 and have characteristics akin to several human-derived broadly neutralizing antibodies.

Legend

Protein

Chemical

Disease

Primary Citation of related structures